Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel Free CRBP Stock Alerts

Corbus Pharmaceuticals (CRBP) Stock Chart & Stock Price History

Corbus Pharmaceuticals logo
$10.38 +0.54 (+5.49%)
As of 08/21/2026 04:00 PM Eastern
Compare

Corbus Pharmaceuticals Stock Price Performance

The Corbus Pharmaceuticals (CRBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 6.03%, with a year-to-date return of 27.52%. In the past month, the stock has increased 17.42%, reflecting recent market activity.

As of the latest close, Corbus Pharmaceuticals traded at $10.38 with a market cap of $193.81 million and volume of 604,014 shares. Five years ago, the stock traded at $1.14, representing a 810.53% increase over that period. At the time, it had a market cap of $142.76 million and a volume of 688,602 shares.

Receive CRBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-1.05%
1 Month
Performance
+17.42%
3 Month
Performance
-8.55%
Year-To-Date
Performance
+27.52%
1 Year
Performance
+6.03%
5 Year
Performance
+810.53%

CRBP Stock Chart for Saturday, August, 22, 2026

CRBP Chart by TradingView

Corbus Pharmaceuticals Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/21/2026$9.84$10.38
+5.49%		$10.42$9.90604,014 shs$193.81 million
08/20/2026$9.99$9.84
-1.50%		$10.05$9.73300,367 shs$183.71 million
08/19/2026$10.08$9.99
-0.89%		$10.42$9.86344,519 shs$186.51 million
08/18/2026$10.49$10.08
-3.91%		$10.75$9.95329,116 shs$188.20 million
08/17/2026$10.09$10.49
+3.96%		$10.58$10.05869,296 shs$195.85 million
08/14/2026$10.08$10.09
+0.10%		$10.29$9.88425,847 shs$188.38 million
08/13/2026$9.76$10.08
+3.28%		$10.39$9.68695,929 shs$188.19 million
08/12/2026$9.51$9.76
+2.63%		$9.91$9.40548,779 shs$182.22 million
08/11/2026$9.46$9.51
+0.53%		$9.71$9.42423,613 shs$176.22 million
08/10/2026$10.17$9.46
-6.98%		$10.25$9.37339,796 shs$175.29 million
08/07/2026$9.74$10.17
+4.41%		$10.23$9.74357,095 shs$188.45 million
08/06/2026$9.57$9.74
+1.78%		$9.84$9.18157,974 shs$180.48 million
08/05/2026$9.40$9.57
+1.86%		$9.82$9.38234,220 shs$177.33 million
08/04/2026$8.92$9.40
+5.33%		$9.45$8.98264,959 shs$174.09 million
08/03/2026$8.97$8.92
-0.56%		$9.16$8.71131,961 shs$165.29 million
07/31/2026$9.05$8.97
-0.88%		$9.16$8.62351,704 shs$166.21 million
07/30/2026$8.91$9.05
+1.63%		$9.36$8.79138,001 shs$165.27 million
07/29/2026$9.09$8.91
-2.04%		$9.19$8.82263,499 shs$165.01 million
07/28/2026$9.08$9.09
+0.11%		$9.33$8.78154,983 shs$168.44 million
07/27/2026$9.17$9.08
-0.98%		$9.54$9.05363,235 shs$168.23 million
07/24/2026$9.32$9.17
-1.61%		$9.36$8.93172,702 shs$169.90 million
07/23/2026$8.84$9.32
+5.43%		$9.48$8.73638,804 shs$172.70 million
07/22/2026$8.98$8.84
-1.56%		$9.10$8.73154,485 shs$163.81 million
07/21/2026$8.89$8.98
+1.01%		$9.05$8.8380,947 shs$166.38 million
Related Companies

This page (NASDAQ:CRBP) was last updated on 8/21/2026 by MarketBeat.com Staff.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Your Free Report (Inside)
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
23,281 stocks. Only ONE survived.
One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...
Monument Traders Alliance | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel